Indication
Chronic Eosinophilic Leukemia
3 clinical trials
5 products
Clinical trial
A Phase I/II Study of Azacitidine, Venetoclax and Pevonedistat in Adults With Newly Diagnosed Secondary or Therapy-Related AMLStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Product
AzacitidineProduct
PevonedistatProduct
VenetoclaxClinical trial
Phase 2 Study of Ruxolitinib in Idiopathic Hypereosinophilic Syndrome and Primary Eosinophilic DisordersStatus: Recruiting, Estimated PCD: 2025-11-30
Product
RuxolitinibClinical trial
A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell TransplantStatus: Completed, Estimated PCD: 2024-02-02